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 The production of bone-forming osteogenic cells for research purposes or 
transplantation therapies remains a signifi cant challenge. Using planar polycarbonate 
substrates lacking in topographical cues and substrates displaying a nanotopographical 
pattern, mesenchymal differentiation of human embryonic stem cells is directed in 
the absence of chemical factors and without induction of differentiation by embryoid 
body formation. Cells incubated on nanotopographical substrates show enhanced 
expression of mesenchymal or stromal markers and expression of early osteogenic 
progenitors at levels above those detected in cells on planar substrates in the same 
basal media. Evidence of epithelial-to-mesenchymal transition during substrate 
differentiation and DNA methylation changes akin to chemical induction are also 
observed. These studies provide a suitable approach to overcome regenerative medical 
challenges and describe a defi ned, reproducible platform for human embryonic stem 
cell differentiation. 
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 In contrast to adult stem cells, human embryonic stem cells 
(hESCs) exhibit infi nite self-renewal and are pluripotent, 
differentiating to endodermal, ectodermal and mesodermal 
lineages. [ 1 ] Maintenance of self-renewal, retention of pluripo-
tency and differentiation requires specifi c intrinsic and 
extrinsic cues, [ 1 ] the latter being provided by the chemical and 
physical surroundings. Thus the opportunity exists to manipu-
late the extrinsic hESC environment in order to obtain medi-
cally relevant cell types for stem cell biology, small molecule 
screening and therapeutic application. 
 Current orthopaedic research focuses on the use adult 
skeletal stem cells (SSCs), present within bone marrow, for 
regenerative therapies with the objective of producing osteo-
genic or chondrogenic cell types for transplantation and repair 
of bone or cartilage. [ 2 ] However, in comparison to ESCs, SSCs 
are in limited supply (constituting 1 in 40 000–100 000 bone 
marrow cells), typically from older patients undergoing total 
hip replacement and display limited proliferation in vitro. 
Thus, ESCs may provide an alternative source of SSCs and 
SSC-derived cells in order to realise therapeutic applications. 
In vitro osteogenic differentiation protocols for mouse ESCs 1H & Co. KGaA, Weinheim wileyonlinelibrary.com
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(mESCs) and hESCs have been reported [ 3–5 ] however, the 
focus for these protocols has typically centred on chemical 
induction and/or embryoid body (EB) formation to induce 
differentiation. 
 We have recently described the manipulation of adult 
SSC differentiation in the absence of soluble factors using a 
defi ned nanotopography of 120 nm diameter pits in a near 
square arrangement. [ 6–8 ] This work highlights an ability of the 
nanoscale physical environment alone to modulate stem cell 
fate. Additionally, nanopit depths of 100 nm but not 10 nm [ 9 ] 
and nanotubes of 70 nm and 100 nm but not 30 nm in diam-
eter [ 10 ] were reported to favor SSC osteoblastic differentia-
tion in the absence of osteogenic chemical cues indicating 
that scale, even within the nano range, is also important. 
Furthermore, the degree of order and disorder of nanotopog-
raphy is elegantly demonstrated by the observations that a 
regular square arrangement of nanopits enhanced the stem 
cell state of SSCs [ 7 ] whereas displacement of that order by 
50 nm induced osteogenic differentiation. [ 6 , 8 ] Osteogenic dif-2
 Figure  1 .  Self-renewal marker expression is reduced following incubation on planar or NSq50 
substrates in basal media. hESCs seeded on matrigel in CM or in hESC medium lacking FGF 
were fi xed after 3 days. hESCs seeded on planar or NSq50 nanotopographies in  α –MEM 
media plus 10% serum were fi xed after 2, 4 (A, scale bars left panels 50  μ M and right panels 
20  μ M), 7 or 14 days (B, scale bars left panels 100  μ M and right panels 20  μ M). Fixed cells 
were stained for OCT4, SOX2, TRA-1-60 or SSEA4 (green) and nuclei counterstained with DAPI 
(blue) (A and B). qPCR was used to assess mRNA expression of NANOG, POU5F1 and SOX2 
following 14 days incubation on planar or NSq50 in basal media (n  = 6) (C). ferentiation of mESCs and hESC has been 
described using nanoscale topography in 
the presence of soluble osteogenic factors 
and/or prior EB formation making it dif-
fi cult to distinguish the effect of surface 
topography alone. [ 11 ] 
 SSCs and mESCs can be cultured on 
a wider range of surfaces compared to 
hESCs, while human pluripotent-derived 
cell types remain the Holy Grail for regen-
erative therapies. To this end, we have 
examined the potential for substrates 
lacking in topographical features, planar, 
and nanotopographical substrates dis-
playing a near square pattern of nanopits 
(NSq50) to infl uence hESC differentiation 
in the absence of soluble, chemical induc-
tion factors and we have investigated the 
resulting changes in gene expression and 
epigenetic markers. 
 2. Results 
 2.1. hESCs in the Presence or Absence of 
Topographical Cues Exhibit a Loss of Self-
Renewal Marker Expression 
 Differentiation of hESCs incubated on 
planar and NSq50 (Figure S1) substrates 
was assessed by immunofl uorescent staining 
for self-renewal markers ( Figure  1 ). On 
matrigel in MEF-conditioned media (CM), 
self-renewing hESCs displayed robust 
positive staining for OCT4 and SOX2 in 
nuclear localisations and TRA-1-60 and 
SSEA4 on the cell surface (Figure  1 A) 
typical of self-renewing ESCs under rou-
tine culture. Following replacement of CM 
for hESC media lacking FGF for 3 days, www.small-journal.com © 2013 Wiley-VCH Vea marked loss of expression of all self-renewal markers was 
observed (Figure  1 A). hESCs seeded on planar substrates in 
basal media ( α –MEM plus 10% serum) exhibited reduced 
staining for OCT4 and SOX2 after 2 days incubation how-
ever, TRA-1-60 and SSEA4 expression remained detectable 
(Figure  1 A). On NSq50 substrates, hESCs also displayed 
reduced OCT4 and SOX2 expression following 2 days of cul-
ture although not as low as cells on planar substrates at this 
time point. 
 Increased incubation led to a further loss of self-renewal 
on the substrates. By day 4, expression of OCT-4, SOX2 and 
SSEA4 was further decreased in cells incubated on planar 
or NSq50 substrates. It is notable that TRA-1-60 remained 
detectable in localised areas (Figure  1 A) particularly on 
planar substrates. Critically, expression of OCT4, SOX2 
and TRA-1-60 were undetectable by day 14 on planar or 
NSq50 substrates (Figure  1 B). SSEA4 expression was strong 
at day 14 on planar but on NSq50 substrates expression 
was negligible. Consistent with a loss of hESC self-renewal rlag GmbH & Co. KGaA, Weinheim small 2013, 
DOI: 10.1002/smll.201202340
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(encodes OCT4) and SOX2 was also signifi cantly reduced 
for hESCs incubated on either planar or NSq50 substrates 
(Figure  1 C). Importantly, comparison of live dead staining 
at days 4 and 12 revealed excellent viability with no discern-
ible differences in the size or number of adhered colonies 
(Figure S2). Furthermore, after 12 days colonies had main-
tained excellent viability and colony size had increased to 
sub-confl uent levels on the 2.5 cm  × 2.5 cm substrates dis-
playing either planar or NSq50 topographies (Figure S2). 
 2.2. Planar and NSq50 Substrates Do Not Direct Endodermal 
or Ectodermal Differentiation 
 To investigate lineage specifi c differentiation, expression of a 
panel of early differentiation markers was assessed by qPCR 
and expression compared to day 14 EBs. At the mRNA level, 
the expression of visceral endodermal marker  α -fetoprotein 
(AFP) was signifi cantly enhanced by differentiation on 
planar or NSq50 substrates compared to self-renewing hESCs 
( Figure  2 A). However, AFP expression was variable and not 
signifi cantly different from expression in day 14 EBs. Expres-
sion of endodermal marker SOX17 was low in hESCs and 
day 14 EBs (Figure  2 A). Following differentiation on planar 
or NSq50 substrates, a signifi cant reduction in expression of 
SOX17 was observed. Claudin6, another endodermal marker, 
was also expressed at a low level in hESCs with a signifi cant 
reduction in expression following incubation on planar or 
NSq50 substrates and a greater reduction observed in day 14 
EBs (Figure  2 A). 
 Ectodermal marker SOX1, was not signifi cantly enhanced 
in cells incubated on either planar or NSq50 substrates © 2013 Wiley-VCH Verlag Gm
 Figure  2 .  Planar and NSq50 substrates do not direct endodermal or ectode
Expression of endodermal (A) and ectodermal (B) markers was assess
renewing hESCs and hESCs seeded onto planar or NSq50 substrates
14 days (n  = 6). C) Following 14 days incubation, cells were fi xed, stain
and counterstained with DAPI (blue). (Scale bars 50  μ m). 
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DOI: 10.1002/smll.201202340compared to hESCs (Figure  2 B). However, a signifi cant dif-
ference in SOX1 expression in cells on NSq50 compared to 
day 14 EBs was observed (Figure  2 B). There is some debate 
as to whether neural differentiation is the default differentia-
tion mode [ 12 ] or that neural lineage differentiation is the fate 
of ESCs when extrinsic signals are minimal. [ 13 ] A signifi cant 
enhancement in nestin expression was detected in day 14 EBs 
compared to hESCs. In contrast, neuroectodermal differen-
tiation was not evident on planar or NSq50 substrates since 
Nestin mRNA expression was almost undetectable in cells 
seeded on planar or NSq50 substrates (Figure  2 B) and PAX6 
expression was undetectable by qPCR in hESCs and hESCs 
seeded on planar or NSq50 for 14 days. Furthermore, cells 
incubated on planar or NSq50 substrates were negative for 
Nestin protein (Figure  2 C). These expression profi les demon-
strate that differentiation on planar or NSq50 substrates does 
not reproducibly induce endodermal or ectodermal cell types 
and for all genes investigated expression on nanotopograph-
ical substrates is distinct from the multiple lineage differen-
tiation observed in EBs. 
 2.3. Nanotopographical Cues Maintain Pan Stem Cell Marker 
Expression and Enhance Mesodermal and Osteogenic Marker 
Expression 
 Expression of nucleostemin, a marker of ESCs, neural stem 
cells, bone marrow-derived SSCs and human cancer cells, [ 14 ] 
was signifi cantly reduced in cells on planar substrates but not 
signifi cantly different in cells on NSq50 substrates compared 
to self-renewing hESCs ( Figure  3 A). Retention of nucle-
ostemin expression after 14 days on NSq50 substrates, cou-
pled with loss of self-renewal marker expression (Figure  1 ) bH & Co. KGaA, Weinheim
rmal differentiation. 
ed by qPCR for self-
 in basal media for 
ed for nestin (green) and absence of neural marker expression 
(Figure  2 ) suggests differentiation towards 
cell types comparable to bone marrow 
stem cells on NSq50 substrates. 
 A statistically signifi cant reduction 
in the expression of mesendodermal 
markers GSC (encodes goosecoid) 
(Figure  3 B) and MIXL1 (Figure  3 C) was 
observed in cells incubated on planar 
and NSq50 substrates compared to self-
renewing hESCs. In contrast, expres-
sion of the pan-mesodermal marker 
T (encodes brachyury) at day 14 was 
not signifi cantly different (Figure  3 D) 
potentially suggesting a rapid transition 
through the mesendodermal stage to 
mesodermal differentiation. BMP4 RNA 
expression was signifi cantly enhanced 
(Figure  3 E) and BMP4 protein expres-
sion was enhanced in cells incubated on 
planar and to a greater extent on NSq50 
substrates (Figure  3 F). 
 Given that SSCs are of mesodermal 
origin giving rise to osteogenic, chondro-
genic and adipogenic lineages, this fi nding 
warranted investigation of SSC marker 3www.small-journal.com
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 Figure  3 .  NSq50 maintains pan-stem cell marker expression and enhances expression of 
mesodermal marker. BMP4 Expression of nucleostemin (n  = 6) (A), GSC (n-5) (B), MIXL1 (n  = 
5) (C), T (n  = 6) (D) and BMP4 (n  = 6) (E), was assessed by qPCR for hESCs and hESCs seeded 
onto planar or NSq50 in basal media for 14 days. Cells were fi xed after 14 days incubation 
and stained for BMP4 (F) (green) and counterstained with DAPI (blue). (Scale bars 50  μ m). expression. CD63, a marker of primitive human marrow 
stromal cells [ 15 ] was signifi cantly enhanced in cells incubated 
on NSq50 substrates but not signifi cantly different in cells 
incubated on planar substrates ( Figure  4 A). Furthermore, 
ALCAM, a marker of bone marrow stromal cells and osteob-
lastic cell lines was signifi cantly enhanced in cells incubated 
on planar with greater expression observed on NSq50 sub-
strates (Figure  4 A). 
 STRO1 is reported as a reliable marker of a bone 
marrow-derived SSC population and osteogenic progenitor 
cells. [ 15–16 ] Low levels of STRO1 expression was detectable 
in hESCs (Figure  4 B). STRO1 expression was enhanced fol-
lowing 7 days on either planar or NSq50 substrates. On day 4 www.small-journal.com © 2013 Wiley-VCH Verlag GmbH & Co. KGaA14, STRO1 expression was similar to that 
observed on day 7 for planar substrates 
but slightly reduced for NSq50 substrates 
(Figure  4 B). CD44 is a marker of bone-
marrow derived mesenchymal stem cells 
(MSCs). [ 17 ] CD44 expression was low in 
hESCs, enhanced following differentia-
tion on planar substrates and enhanced to 
a greater extent on NSq50 substrates on 
day 7 (Figure  4 B). CD44 expression on 
planar substrates was further enhanced 
at day 14. CD44 expression on NSq50 
substrates had reduced slightly by day 14 
compared to day 7. Thus, cells differen-
tiating on NSq50 substrates appeared to 
strongly gain and then exhibit a reduc-
tion in expression of CD44 and STRO1 
protein. One possible explanation for 
this is that NSq50 augments or extends 
the differentiation of hESCs beyond that 
achieved by planar substrates, possibly 
towards SSC-like cell types. At day 14, 
CD44 mRNA expression was signifi cantly 
enhanced in cells on NSq50 substrates 
although not in cells on planar substrates 
compared to hESCs (Figure  4 C) indi-
cating an overall enhancement in the 
expression of CD44. 
 Consistent with temporal changes in 
CD44 and STRO1 expression on NSq50 
substrates, later markers of primitive 
human stromal cell differentiation were 
detected at day 14. Collagen type I (bone-
specifi c) was enhanced signifi cantly in 
cells incubated on planar substrates and 
to a greater extent in cells incubated on 
NSq50 substrates (Figure  4 D). Expres-
sion of collagen type I protein by cells 
differentiated on planar and NSq50 for 
14 days was confi rmed by immunofl uores-
cent staining (Figure  4 E). Collagen type 
II (cartilage-specifi c) was signifi cantly 
enhanced on either planar or NSq50 sub-
strates (Figure  4 F). RUNX2, a critical 
transcription factor for induction of osteo-
genic differentiation, [ 18 ] and osteonectin, a bone-specifi c protein forming complexes with collagen, [ 19 ] 
were signifi cantly enhanced on planar and NSq50 substrates 
(Figure  4 F). Conversely, PPAR γ , reported to be involved in 
early mesodermal induction and adipogenesis [ 20 ] was unde-
tectable by qPCR in hESCs or hESCs differentiated on 
planar or NSq50 substrates for 14 days. 
 Taken together, these observations indicate directed-
differentiation of hESCs towards mesenchymal cell types by 
either planar or NSq50 substrates in the absence of chemical 
induction factors. However, differences in the expression 
profi les of the markers investigated (namely Nucleostemin, 
CD63, CD44 and STRO1) indicate that nanotopographical 
cues provided by NSq50 substrates infl uence cell fate in a , Weinheim small 2013, 
DOI: 10.1002/smll.201202340
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 Figure  4 .  NSq50 enhances expression of skeletal stem cell and osteogenic progenitor markers. 
Expression of CD63, ALCAM (n  = 5) (A), CD44 (n  = 3) (C), collagen type I (D), collagen type II, 
RUNX2 and osteonectin (n  = 6) (F) was assessed by qPCR for hESCs and hESCs seeded onto 
planar or NSq50 in basal media for 14 days. Cells were fi xed after 7 and 14 days incubation, 
stained for STRO1, CD44 (B) or collagen type I (E) (green) and counterstained with DAPI (blue). 
(Scale bars 50  μ m). manner that differs from planar substrates. NSq50 substrates 
augment hESC mesenchymal differentiation to produce cells 
expressing SSC markers. 
 In contrast to hESCs, EBs were less sensitive to nano-
topographical cues for mesoderm/mesenchymal differen-
tiation. Despite adherence and outgrowth of day 4 EBs on 
planar and NSq50 substrates (Figure S4A), no indication of 
directed differentiation by planar or NSq50 substrates was 
observed. EB-derived cells exhibited expression of markers 
representing all three germ layers and no apparent trends in 
germ layer marker expression (Figure S4B). Thus, following 
EB formation, cells appeared to be less responsive to both 
a lack of topography and to nanotopography-induced meso-
dermal differentiation. © 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheismall 2013, 
DOI: 10.1002/smll.201202340 2.4. Nanotopographical Cues Induce 
Morphology and Changes in Adhesion 
Protein Expression Similar to Those 
Observed During Epithelial to Mesen-
chymal Transition 
 Cell morphology was investigated by 
bright fi eld microscopy at days 2, 5, 9, 
and 12 after seeding ( Figure  5 ). Cell mor-
phology was similar for hESCs seeded on 
planar or NSq50 substrates on days 2, 5, 
and 9. However at day 12, the cell popu-
lation on planar substrates displayed a 
more heterogeneous appearance with 
some overlapping cells. On NSq50 sub-
strates, cells were arranged in a mono layer 
with a high degree of cell-cell contact 
surface area (Figure  5 ). This epithelial-
like cell morphology observed on NSq50 
substrates was similar to that reported by 
Chen and co-workers using TGF- β inhibi-
tion to induce mesenchymal differentia-
tion of ESCs. [ 21 ] 
 Epithelial to mesenchymal transi-
tion (reviewed by Lee et al) [ 22 ] occurs 
during gastrulation when mesodermal and 
endodermal cell populations are formed. 
Reciprocal expressional changes in 
E-cadherin and N-cadherin are reported 
to be a hallmark of this process in pluripo-
tent cells. [ 21 , 23 ] Expression of E-cadherin 
protein was detected in cells cultured on 
planar and NSq50 substrates for 5 days 
( Figure  6 A). After 10 days expression was 
reduced and after 14 days protein expres-
sion was almost undetectable on planar or 
NSq50 substrates (Figure  6 A). E-cadherin 
mRNA expression was not signifi cantly 
different in cells incubated for 14 days on 
planar substrates (Figure  6 B). However, a 
statistically signifi cant reduction in E-cad-
herin mRNA expression was observed in 
cells differentiated on NSq50 substrates 
for 14 days compared to self-renewing 
hESCs (Figure  6 B) correlating with pro-tein expression (Figure  6 A). 
 In contrast, expression of N-cadherin was detectable at 
day 5 although to a greater extent in cells seeded on NSq50 
substrates (Figure  6 C). On either substrate N-cadherin 
expression was signifi cantly reduced on day 10 compared to 
day 5. For cells on planar substrates, expression remained 
low on day 14 but on NSq50 substrates expression was sig-
nifi cantly enhanced on day 14. The observation of a loss of 
E-cadherin expression on either substrate is consistent with 
differentiation of hESCs. However, cells on NSq50 substrates 
also exhibited an enhancement in N-cadherin expression 
which, taken together with reduced E-cadherin expression, 
is consistent with the epithelial to mesenchymal transition 
process in ESCs. [ 21 , 23 ] 5www.small-journal.comm
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 Figure  5 .  hESC morphologies during differentiation on planar and NSq50 substrates. hESCs 
were seeded onto planar and NSq50 substrates and incubated for 12 days. Bright fi eld 
microscopy images were taken on days 2, 5, 9, and 12. (Scale bars 100  μ m or 200  μ m as 
indicated.)  The zinc fi nger transcription factors and repressors of 
E-cadherin transcription SLUG [ 24–25 ] and SNAIL [ 26 ] are 
reported induce epithelial to mesenchymal transition. [ 24 , 27 ] 
Furthermore, the repression of SLUG in the developing 
embryo prevents primitive streak mesoderm formation [ 28 ] 
while SLUG/SNAIL expression has previously been reported 
in ESC differentiation during epithelial to mesenchymal 
transition. [ 29 ] hESCs incubated on planar and NSq50 for 
5 days displayed a low level of nuclear SLUG/SNAIL expres-
sion (Figure  6 D). By day 10, expression of SLUG/SNAIL was 
enhanced in cells on either surface. Localisation of SLUG/
SNAIL remained predominantly nuclear for cells on planar 
substrates but both nuclear and cytoplasmic staining was 
observed in cells on NSq50 substrates. At day 14, expression 
of SLUG/SNAIL was detected within the nuclei and at low 
levels in the cytoplasm of cells incubated on planar substrates. 
Expression SLUG/SNAIL was enhanced to a greater extent 
in cells incubated on NSq50 substrates for 14 days with both 
nuclear and cytoplasmic localisation (Figure  6 D). 
 2.5. NSq50 Induces a ‘Mesenchymal Stem Cell’–Like Cell 
Phenotype 
 To fully characterise the differentiated cell types, MSC PCR 
arrays with 84 mesenchymal-focused genes, 5 house-keeping 
genes and 7 internal controls were employed. A hierarchical 
clustering heatmap depicts the differences in gene expres-
sion ( Figure  7 A). Notably, hESCs differentiated on planar 
and NSq50 substrates are distinct from self-renewing hESCs. 
Moreover, differential gene expression between cells incu-
bated on planar substrates or on NSq50 substrates was evi-
dent (Figure  7 A). PCR Array data highlighted 10 genes 6 www.small-journal.com © 2013 Wiley-VCH Verlag GmbH & Co. KGaA,down-regulated at least 2 fold (i.e. fold 
regulation  < -2) following differentiation 
on planar or NSq50, in comparison to self-
renewing hESCs. Self-renewal markers 
FGF2, POU5F1, SOX2 and REX1 were 
signifi cantly down-regulated by at least 
2 fold following differentiation on planar 
or NSq50 (Figure  7 B). Incubation on 
planar resulted in 35 genes up-regulated 
greater than 2 fold whilst differentiation 
on NSq50 induced up-regulation greater 
than 2 fold for 36 genes, with 32 genes 
mutually up-regulated. The fi ltered data 
set identifi ed eleven genes up-regulated 
to a greater extent on NSq50 than on 
planar when compared to self-renewing 
hESCs (Figure  7 C) of which eight genes 
are specifi cally expressed by or associ-
ated with MSCs, two are associated with 
osteogenesis and one associated with mes-
odermal differentiation (Table S3). Fur-
thermore, enhanced expression of MSC 
and osteogenic lineage markers (broadly 
and namely CD44 and collagen type I) 
by NSq50 substrates compared to planar 
substrates identifi ed by PCR array is in agreement with our qPCR and immunofl uorescent staining 
observations (Figure  4 ). 
 Differential expression (identifi ed by normalising NSq50 
PCR array data to planar data) (Figure  7 D) highlighted two 
genes up-regulated greater than 1.5 fold on NSq50; Hepato-
cyte nuclear factor 1 alpha (HNF1A), is reported to enhance 
MSC proliferation downstream of Wnt signalling and to delay 
osteogenic maturation, [ 30 ] and protein tyrosine phosphatase, 
receptor type C (PTPRC), a stromal cell marker, were up-
regulated 1.96 and 1.72 fold respectively in cells incubated 
on NSq50 (Figure  7 D). Additionally, 10 genes were down-
regulated greater than 1.5 fold in cells incubated on NSq50 
(Figure  7 D); including PPAR γ , an inducer of adipogenic dif-
ferentiation, [ 20 ] which was undetectable by the less sensitive 
method of qPCR (Section 3.3). Interestingly, siRNA-medi-
ated knockdown of PPAR γ has been reported to enhance 
osteogenic marker expression in mESCs. [ 31 ] Differential gene 
expression highlights the infl uence of discrete nanopit pat-
tern displayed by NSq50 substrates on directed differentia-
tion of hESCs. 
 2.6. Methylation Status of POU5F1 and Osteocalcin Promoters 
Following Differentiation on Planar and NSq50 
 Following signifi cant expression profi le changes in cells incu-
bated on planar and NSq50, changes at an epigenetic level 
were determined. Global methylation of hESCs and fol-
lowing incubation on planar or NSq50 substrates was not sta-
tistically different (Figure S3). POU5F1 contains a number 
of CpG sites upstream and downstream of the transcription 
initiation site, at which methylation corresponds to reduced 
transcription and reduced expression of OCT4. [ 32 ] In general,  Weinheim small 2013, 
DOI: 10.1002/smll.201202340
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 Figure  6 .  Reciprocal expression changes of E-cadherin and N-cadherin during planar and 
NSq50 substrates-induced mesenchymal differentiation Cells were fi xed after 5, 11, and 
14 days incubation on planar or NSq50 substrates, stained for E-cadherin (A), N-cadherin 
(C) or SLUG/SNAIL (D) shown in green in upper panels. Middle panels show merged images 
of staining and DAPI counterstain (blue). (Scale bars 100  μ m). Fluorescence intensity of 
E-cadherin and N-cadherin immunostaining was quantifi ed and represented graphically as 
a mean (n  = 3) with standard deviation (A and C lower panels). Expression of E-cadherin 
(B) was assessed by qPCR for hESCs and hESCs seeded onto planar or NSq50 in basal media 
for 14 days. hypomethylation of CpG sites in POU5F1 promoter region 
( Figure  8 A) was detected in hESCs which was enhanced fol-
lowing removal of CM to induce differentiation (Figure  8 B), 
consistent with a loss of OCT4 expression (Figure  1 ). Specifi -
cally, for CpG sites 109 base pairs upstream and 4, 29, 39, 79, 
and 87 base pairs downstream of the transcription initiation 
site, incubation on planar or NSq50 substrates induced a sig-
nifi cant increase in methylation compared to self-renewing 
hESCs (Figure  8 B) correlating with a loss of OCT4 expression 
(Figure  1 ). Moreover, methylation levels in nanotopography-
differentiated hESCs were not statistically different from 
levels in cells induced to differentiate by withdrawal of CM. 
 Following observation of enhanced SSC and early oste-
oinductive marker expression including RUNX2 (Figure  4 ), © 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheismall 2013, 
DOI: 10.1002/smll.201202340the methylation status of osteocalcin, a 
target of RUNX2 and secreted protein 
marker of osteoblasts, [ 33 ] was assessed. 
Methylation within the osteocalcin pro-
moter region (Figure  8 C) can be coupled 
to the developmental stage of the cell type 
prior to detectable expression of osteo-
calcin. [ 34 ]  Hypermethylation was detected 
within this region in hESCs and fetal 
femur explants (Figure  8 D). However, at 
CpG sites 572, 559, 517, 476 and 468 base 
pairs upstream of the osteocalcin start 
site, methylation of fetal femur explants 
was statistically signifi cantly lower than 
levels detected in hESCs. Following differ-
entiation on planar and NSq50, methyla-
tion did not fall below levels detected in 
fetal femur explants indicating epigenetic 
characteristics comparable to a primitive, 
embryonic or early fetal form of stromal/
osteogenic cell-type. 
 3. Discussion 
 Seminal publications have highlighted 
the importance of substrate surface 
nanotopography, [ 6–7 ] stiffness [ 35 ] and 
chemistry [ 36–38 ] in manipulating MSC dif-
ferentiation however, to date, directed dif-
ferentiation of hESCs in the absence of 
chemical cues remains elusive. We have 
demonstrated the effi cient adherence and 
differentiation of hESCs on planar sub-
strates and a substrate displaying a near 
square arrangement of nanopits (NSq50). 
Both planar and NSq50 substrates directed 
the differentiation of hESCs towards a 
mesodermal lineage in the absence of 
chemical induction and without induction 
of differentiation by EB formation. How-
ever, a number of signifi cant observations 
indicate that NSq50 substrates are more 
effi cient at directing mesenchymal/stromal 
differentiation than planar substrates. Spe-cifi cally, retention of Nucleostemin, a signifi cant enhancement 
in CD63 and ALCAM, a signifi cant reduction in E-cadherin 
expression, temporal expression of CD44 and STRO1, up-
regulation of markers associated with stromal/mesenchymal 
cell types and down-regulation of markers associated with 
non-stromal/mesenchymal cell types were observed in cells 
on NSq50 but not planar substrates. 
 Previous reports detailing mESC-derived osteogenic cells 
via cell aggregation or bioreactor-differentiation protocols 
indicate the maintenance of a sub-population of teratoma-
forming undifferentiated ESCs. [ 3 , 39 ] Here, protein expres-
sion of OCT4, SOX2 and TRA-1-60 was undetectable after 
14 days on NSq50. Naturally, the complete absence of undif-
ferentiated cells following nanotopographical differentiation 7www.small-journal.comm
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 Figure  7 .  Gene expression profi le of hESCs cultured on planar and NSq50. Gene expression was 
profi led using MSC RT2 PCR array for self-renewing hESCs (n  = 1) and for hESCs differentiated 
for 14 days on planar (n  = 3) or NSq50 (n  = 3) substrates. Cluster analysis is represented as 
a heat map where low to high expression is represented by dark red to white (A). PCR array 
data was analysed online with RT2 Profi ler PCR Array Data Analysis (SA Biosciences) tool 
and normalised to self-renewing hESCs (B and C) or to planar (D). B Self-renewal marker 
genes down-regulated greater than 2 fold following culture on planar or NSq50. (C) Genes 
up-regulated greater than 2 fold were fi ltered for genes up-regulated more on NSq50 than on 
planar. (D) Genes differentially expressed following culture on NSq50 compared to planar. would need to be confi rmed by in vivo studies. SSEA4 was 
detected in hESCs differentiated on planar substrates and at 
very low levels in hESCs differentiated on NSq50 substrates. 
SSEA4 expression was reported in bone marrow aspirate 
cells, [ 40 ] human fi rst-trimester fetal MSCs [ 41 ] and circulating 
SSEA4 + cells of bone marrow origin were reported to be 
detected in patients with acute myocardial infarction. [ 42 ] 
These reports suggest that our observation of SSEA4 expres-
sion in hESC-derived mesenchymal/stromal cells supports 
the mesenchymal phenotype of these cells. 
 Neural differentiation of hESCs is reported as the default 
lineage [ 12 ] or the lineage favoured in the absence of chemical 
cues in the culture media. [ 13 ] Expression of neural markers 
PAX6 and nestin were undetectable at the mRNA and protein 
levels respectively in hESCs incubated for 14 days on planar 
or NSq50 substrates. However, this cell line has capactiy for 
neural differentiation evidenced by the expression of Pax6 
and nestin in EBs. Furthermore, others report a bias of some www.small-journal.com © 2013 Wiley-VCH Verlag GmbH & Co. KGaAcell lines towards mesodermal differentia-
tion. [ 43 ] Importantly, we found no evidence 
of a spontaneous mesodermal propensity 
of this cell line since expression of markers 
representing all three germ layers were 
detectable in EBs indicating multiple lin-
eage differentiation capacity. Induction of 
differentiation by EB formation prior to 
seeding reduced the susceptibility to infl u-
ence by either the absence or presence of 
nanotopographical cues. In part, this can 
be attributed to cell-surface contact since 
EBs exhibited outgrowth on all surfaces 
but had already formed cell-cell contacts 
thus reducing cell-substrate contact upon 
seeding consistent with the procedure of 
optimising cell-surface contact in order to 
maximise cell-surface infl uence over and 
above cell-cell contact. [ 35 ] It has previously 
been reported that EB formation prior 
to chemically-induced osteogenic differ-
entiation is not essential and may, in fact, 
limit osteogenic potential. [ 5 , 44 ] Moreover, 
in light of surface stiffness [ 35 ] and cell 
shape [ 36 ] coupling to cell fate, Chowdhury 
et al. demonstrated that undifferentiated 
mESCs were seven times softer (higher 
cell deformation in response to the same 
applied stress) and exhibited greater 
spreading in response to local cyclic stress 
compared to differentiated mESCs. [ 45 ] A 
reduction in the softness of cells subse-
quent to differentiation by EB formation 
may prevent nanotopographical infl uence 
on cell shape and inhibit nanotopograph-
ical-directed differentiation. 
 Sox17 expression is required for endo-
derm specifi cation in mice but is not 
expressed in mesodermal, ectodermal or tro-
phectodermal lineages. [ 46 ] D’Amour et al., 
reported elevated expression of SOX17, GSC and MIXL1 in activin A-induced hESC differentiation 
to defi nitive endoderm. [ 47 ] In addition, Claudin6 is reported 
to be expressed in derivatives of defi nitive endoderm. [ 48 ] We 
observed no enhancement in the expression of these markers 
in cells incubated on planar or NSq50 substrates suggesting 
that the population of cells is not endodermal. Brachyury is 
expressed in mesendoderm and mesodermal lineages and is 
reportedly required for mesoderm induction. [ 49 ] In contrast to 
GSC and MIXL1, expression of T, the gene encoding brachyury, 
was not signifi cantly different in cells differentiated on planar 
or NSq50 substrates. In this instance we postulate that a small 
number of cells had retained T expression at day 14 while most 
cells had differentiated past this stage. 
 Cells incubated on NSq50 substrates displayed enhanced 
expression of markers of mesenchymal, stromal and early 
osteogenic progenitors above that detected in cells on planar 
substrates in the same basal media. Up-regulated expres-
sion of E-cadherin transcriptional repressors SLUG/SNAIL , Weinheim small 2013, 
DOI: 10.1002/smll.201202340
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 Figure  8 .  Methylation status of POU5F1 and osteocalcin promoter regions following 
differentiation on planar and NSq50 POU5F1 (A) and osteocalcin (C) promoter regions were 
analysed for CpG methylation by pyrosequencing. The percentage methylation of the POU5F1 
promoter region CpG sites for self-renewing hESCs, cells incubated for 14 days on tissue 
culture plastic in hESC medium lacking FGF (‘-FGF’), on planar or NSq50 substrates in basal 
medium is shown (n  = 3) (B). The percentage methylation of the osteocalcin promoter region 
for self-renewing hESCs (n  = 4), cells incubated for 14 days on planar or NSq50 substrates in 
basal media (n  = 4) and fetal femur explants (‘F.F.’) (n  = 5) is shown (D). and localization within the nucleus coupled with a temporal 
down-regulation of E-cadherin and reciprocal up-regulation 
of N-cadherin protein expression following planar or NSq50 
substrate differentiation of hESCs indicates an epithelial to 
mesenchymal transition during differentiation on substrates. 
Expression of SLUG/SNAIL was greatest in cells incubated 
in NSq50 substrates correlating with our observations of 
epithelial-like cell morphologies on NSq50 but not planar. 
Evidence of this transition further supports mesenchymal lin-
eage differentiation. 
 The ability of nanotopographical cues to modulate cell 
types within this lineage has previously been reported. We 
have formerly described osteogenic differentiation of SSCs 
by NSq50 substrates [ 6 ] and retention of MSC stemness by a 
square arrangement of nanopits. [ 7 ] The nanoscale architecture 
of MSC osteoid was reported to inform skeletal tissue gen-
eration. [ 50 ] Moreover, osteoblast or adipocyte formation was 
reported to be modulated by spatial fi bronectin distribution 
which induced altered MSC tension, highlighting regulation 
by geometric cues. [ 37 ] The importance of matrix stiffness in 
myogenic and osteogenic MSC differentiation has also been © 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheismall 2013, 
DOI: 10.1002/smll.201202340reported. [ 35 ] However, hESCs represent a 
more challenging cell type yet potentially 
more diverse in prospects for regenerative 
medicine and tissue engineering. Despite 
the apparent absence of a completely fl at 
surface in vivo we have demonstrated a 
cellular response to planar substrates and 
by implementing a nanopit arrangement 
on substrates of the same format, chemical 
and physical composition we have dem-
onstrated an augmentation of this cellular 
response. Moreover, our studies were con-
ducted in the absence of soluble chemical 
induction factors and without applying 
a functionalized surface coating to sub-
strates. These steps have isolated, as far 
as possible, nanotopographical cues from 
soluble chemical, insoluble chemical and 
surface stiffness factors. Clues to a mecha-
nism linking nanotopographical sensing 
might be found in tension, nanomechanical 
and cell spreading studies which heavily 
implicate cytoskeletal components. A 
conformational change in vimentin is sug-
gested to protect the cytoplasm from large 
deformation [ 51 ] while vimentin phospho-
rylation by Rho-associated kinase medi-
ates the cellular shape changes of neurite 
retraction. [ 52 ] In mESCs, stress-induced 
spreading was reported to be dependent 
on myosin light chain phosphorylation 
and the expression of cdc42 and Src. [ 45 ] 
Chen and co-workers demonstrated that 
integrin-mediated focal adhesions and 
E-cadherin regulate hESC sensing of 
topographical cues and that, on a smooth 
glass surface, self-renewal marker OCT3/4 
positive cells have a greater spread area than OCT3/4 negative cells. [ 53 ] Moreover, focal adhesion 
formation and E-cadherin have recently been implicated 
in both cytoskeleton contractility and mechanoresponsive 
differentiation. [ 54 ] 
 4. Conclusion 
 We have illustrated the potential of a planar substrate lacking 
in topographical cues, to modulate hESC differentiation 
towards mesodermal lineages. Substrates displaying a near 
square arrangement of nanopits provide enhance directed 
mesodermal differentiation of hESCs with a greater effi -
ciency than planar substrates. The mechanisms by which nan-
otopography might induce mesodermal differentiation likely 
include expressional changes in adhesion proteins and regu-
lators of epithelial to mesenchymal transition. In addition, 
the mechanism involves methylation changes akin to chemi-
cally induced induction. Nanotopography-induced differen-
tiation provides a non-intrusive, facile approach for hESC 
culture in the absence of chemical cues. Cells produced by 9www.small-journal.comm
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nanotopography-induced differentiation have wide applica-
tions in stem cell biology research, small molecule screening 
and therapeutic applications in regenerative medicine and 
tissue engineering. 
 5. Experimental Section 
 Materials : Nanotopography substrates were made as previ-
ously detailed. [ 6 ] In brief, silicon masters of either planar or near 
square pattern of nanopits were used to imprint polycarbonate 
by hot-embossing. Nanopit dimensions of 120 nm diameter and 
100 nm deep were positioned in a near square geometry with 
an average centre spacing of 300 nm  ± 50 nm from true centre 
(NSq50) (Figure S1). 
 Fetal Femur Explant Preparation : All human fetal bones used 
in this study were obtained, following informed written consent, 
after termination of pregnancy with ethical approval from the 
Southampton & South West Hampshire Local Research Ethics 
Committee. Human fetal femurs and long bones were dissected 
and surrounding soft tissue removed. Fetal bones were sliced into 
small pieces and incubated with 1 mg/ml collagenase B overnight. 
The cell suspension was fi ltered to remove debris and cells pel-
leted under centrifugation. The cell pellet was lysed and RNA/DNA 
isolated using AllPrep RNA/DNA Kit (Qiagen). 
 Cell Culture : Maintenance of HUES-7 hESCs (D. Melton, Howard 
Hughes Medical Institute/Harvard University) was conducted on 
 γ -irradiated MEFs in Knockout DMEM (Invitrogen) supplemented 
with 10% knockout serum replacement (Invitrogen), L-glutamine 
(1 mM) (Invitrogen),  β -mercaptoethanol (50  μ M) (Sigma), non-
essential amino acids (0.1 mM) (Invitrogen), basic FGF (10 ng/mL) 
(Peprotech Ltd, London, UK) and penicillin/streptomycin (100  μ g/
mL) (Invitrogen). Subsequent maintenance of HUES-7 on matrigel-
coated (BD Biosciences) tissue culture plastic with 24 h MEF-
 conditioned medium (C. M.) followed. All cell culture was 
conducted at 37  ° C in atmospheric ( ∼ 20%) oxygen. 
 Seeding Nanotopography Substrates with ESCs : Prior to seeding, 
nanotopography surfaces were incubated in antibiotic/antimycotic 
solution (Sigma) overnight, washed twice with PBS followed by one 
wash with medium. ESCs were dissociated from matrigel-coated 
tissue culture plastic by incubating with 1 mg/mL collagenase (Inv-
itrogen) for 5 min at 37  ° C followed by manual cell scraping. ESCs 
were seeded onto nanotopography surfaces by 1:3 passage (a den-
sity comparable to general maintenance passage on matrigel-coated 
tissue culture plastic) in basal media ( α -MEM (Sigma) supplemented 
with 10% FCS (Invitrogen) and penicillin/streptomycin (Lonza)). 
Media was changed twice weekly. Cells were harvested, lysed and 
RNA/DNA isolated using AllPrep RNA/DNA Kit (Qiagen). 
 Embryoid Bodies : Embryoid bodies (EBs) were formed by 
manual scraping of day 3 hESCs cultured on MEFs. Dissociated 
cells were transferred to non-adherent stereological plates in 
Knockout DMEM supplemented with 10% FCS, glutamine (1 mM), 
penicillin/streptomycin (100  μ g/mL), MEM non-essential amino 
acids (0.1 mM) and  β -mercaptoethanol (3.5  μ M). Plates were 
placed on a swirling platform at 37  ° C for 4 days. EBs were col-
lected and resuspended in basal media prior to seeding nano-
topography substrates. 
 Immunofl uorescence : Live dead staining was conducted using 
Cell Tracker Green CMFDA (5-chloromethylfl uorescein diacetate) 0 www.small-journal.com © 2013 Wiley-VCH V(C7025, Invitrogen) and ethidium homodimer-1 (E1169, Invit-
rogen). For immunofl uorescent staining, cells were fi xed directly 
on matrigel-coated tissue culture plastic, planar or NSq50 sub-
strates using 4% paraformaldehyde. Following 10 min incuba-
tion, cells were washed with PBS and incubated for 10 min with 
permeabilisation buffer (0.1% Triton X in PBS). Cells were blocked 
with 1% BSA (Sigma-Aldrich) in PBS for 5 min. Primary antibodies 
BMP4 (Abcam39973), CD44 (Protein Tech 15675-1-AP), type I 
collagen (LF 68, Dr. Larry Fisher, NIH, Bethesda, MD), E-cadherin 
(Abcam ab15148), N-cadherin (Abcam ab12221), nestin (Santa 
Cruz 20978) ( α -nestin antibody was tested on mouse brain sec-
tions), OCT4 (Abcam 19857), SLUG/SNAIL (Abcam ab85931), 
SOX2 (Millipore AB5603), SSEA4 (Abcam 16287), STRO1 (hybri-
doma supernatant, Dr. J. Beresford, University of Bath), TRA-1-60 
(Abcam 16288) or appropriate isotype control antibodies were 
diluted in 1% BSA blocking buffer and applied to cells overnight 
at 4  ° C. Three washes with PBS Tween (0.5%) for 5 min each were 
conducted prior to applying secondary antibody (Alexa fl uor 488) 
diluted in BSA (1%) blocking buffer. Nuclei were counter stained 
with 1:200 DAPI (4′,6-diamidino-2-phenylindole) (D3571, Invit-
rogen) in PBS for 5 min followed by three washes with PBS Tween 
for 5 minutes each. All images were captured on a Carl Zeiss Axio-
vert 200 microscope with Axiovision software (version 4.5) via an 
AxioCam HR digital camera for phase images or via an AxioCam 
MRc with appropriate fi lters for fl uorescence microscopy. Fluores-
cence intensity was quantifi ed using Image J software (NIH) and 
is represented graphically as mean fl uorescence intensity (n  = 3) 
with standard deviation. 
 Quantitative PCR : Isolated RNA was DNase treated and reverse 
transcribed using Super-Script First-strand synthesis system for 
PCR (Invitrogen). Assessment of marker expression was conducted 
by quantitative PCR (qPCR) using Power Sybr Green PCR Master Mix 
(Applied Biosystems). Forward and reverse primers used for qPCR 
are listed in Table S1. For all experiments, data are represented 
as relative fold change in expression following normalisation to 
 β -Actin with standard error of the mean (SEM). 
 PCR Arrays : Isolated RNA was converted to cDNA using RT2 
fi rst strand kit (330401, SA Biosciences) according to the manufac-
turer’s instructions. Subsequently, cDNA was mixed with RT2 qPCR 
master mix and aliquots transferred to 96 well mesenchymal stem 
cell (MSC) PCR array plates (PAHS-082, SA Biosciences). Three 
independent experiments were conducted and data were ana-
lysed using the online RT2 Profi ler PCR Array Data Analysis (SA Bio-
sciences) tool by normalising to GAPDH and  β -Actin housekeeping 
genes and subsequently represented as fold regulation compared 
to self-renewing hESC samples (hESCs maintained on matrigel in 
CM) or day 14 planar control samples as indicated in fi gure leg-
ends. Cluster analysis was performed on mean Ct values normal-
ised to  β -Actin using MatLab (Version 7). 
 Global Methylation Analysis : Genomic DNA was used to inves-
tigate global methylation using MethylFlash Methylated DNA 
Quantifi cation Kit (Epigentek) according to the manufacturer’s 
instructions. DNA from three independent experiments is repre-
sented as a mean percentage of relative global methylation levels 
with SEM. 
 Promoter Methylation Analysis : Genomic DNA was subjected 
to bisulfi te conversion using EZ DNA Methylation-Gold Kit (D5005, 
Zymo). Promoter regions were amplifi ed using specifi cally designed 
primers (Table S2) and Platinum PCR Supermix (11306016, erlag GmbH & Co. KGaA, Weinheim small 2013, 
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